Position in VRTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$12,537,950
+$8,850,774 QoQ
Shares Held
28,078
+245.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CIBC WORLD MARKET INC. holds $46,729,574 across 25 Biotechnology names. VRTX ranks #2 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GMAB |
Genmab A/S
|
488,266 | $13,100,176 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
28,078 | $12,537,950 | |
| 3 | MRNA |
Moderna, Inc.
|
69,817 | $3,546,703 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,766 | $2,909,762 | |
| 5 | RPRX |
Royalty Pharma plc
|
47,426 | $2,275,025 | |
| 6 | EXEL |
Exelixis, Inc.
|
38,204 | $1,638,569 | |
| 7 | ASND |
Ascendis Pharma A/S
|
6,381 | $1,459,526 | |
| 8 | DYN |
Dyne Therapeutics, Inc.
|
69,215 | $1,254,867 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,537,950 | 28,078 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,687,176 | 8,133 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,225,547 | 8,236 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $13,709,488 | 30,794 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,022,617 | 14,485 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,230,977 | 15,473 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $6,078,130 | 13,069 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,290,691 | 13,421 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $4,922,903 | 11,777 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,227,993 | 10,391 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,862,943 | 8,233 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,607,909 | 13,094 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $828,634 | 2,630 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,088,989 | 3,771 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $976,328 | 3,372 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,216,205 | 4,316 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,728,143 | 6,622 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $858,416 | 3,909 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $292,895 | 1,363 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $233,976 | 990 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $699,348 | 2,570 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $757,418 | 2,609 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,264,301 | 17,921 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||